|
Real-time Estimate
Cboe BZX
09:31:04 13/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 76.08 USD | -0.15% |
|
-1.58% | +28.62% |
| 31/07 | Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 30/07 | Ingevity's Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diversified Chemicals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 261.93Cr | |||||
| 7.49TCr | |||||
| 5.1TCr | |||||
| 1.82TCr | |||||
| 1.47TCr | |||||
| 1.06TCr |
- Stock Market
- Stocks
- NGVT Stock
- Charts Ingevity Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
